Leukotrienes and The Lipoxygenases Pathways

References

• Corey EJ, Niwa H, Falck JR, Mioskowski C, Arai Y and Marfat A. In: Samuelsson B, Ramwell PW and Paoletti R, eds. Recent Studies on the chemical synthesis of eicosanoids. Advances in Prostaglandins and Thromboxane Research. New York: Raven Press, 1980; 6: 19–25.
   Google Scholar
• Flower RJ. In: Vane JR and Ferreira SH, eds. Prostaglandins and related compounds. Handbook of experimental Pharmacology. Berlin, Heidelberg, New York: Springer Verlag, 1978; 50/1: 374–422.
   Google Scholar
• Dyerberg J and Bang HO. All cis-5, 8, 11, 14, 17-eicosapentaenoic acid and triene prostaglandins: potential anti-thrombotic agents. Scand J Clin Lab Invest., 1980; 40: 589–93.
   Google Scholar
• Jones RL. In: Rainsford KD and Ford-Hutchinson AW, eds. Pathways of arachidonic acid metabolism. Agents and Actions, (suppl. 6 Prostaglandins and Inflammation). Basel, Boston Stuttgart: Birkhauser Verlag, 1979: 19–26.
   Google Scholar
• Hamberg M and Samuelsson B. Prostaglandin endoperoxides. Novel transformationsof arachidonic acid in human platelets. Proc Nat Acad Sci., U.S.A. 1974; 71: 3400–4.
   Google Scholar
• Nugteren DH. Arachidonate lipoxygenase in blood platelets. Biochim Biophys Acta, 1975; 380; 299–307.
   Google Scholar
• Smith MJH. Lipoxygenase products: release and activities. Chairman’s introductory remarks. Agents and Actions., 1980; 10: 540.
   Google Scholar
• Randall RW, Eakins KE, Higgs GA, Salmon JA and Tateson JE. Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Agents and Actiojis., 1980; 10: 553–5.
   Google Scholar
• Samuelsson B, Hammarstrom S and Borgeat P. In: Weissmann G, Samuelsson B and Paoletti R, eds. Pathways of arachidonic acid metabolism. Advances in Inflammation Research. 1979; 1: 405–12.
   Google Scholar
• Hamberg M and Samuelsson B. On the mechanism of the biosynthesis of prostaglandins E, and F, a. J Biol Chetn., 1967; 242: 5336–43.
   Google Scholar
• Nutgeren DH, Beerthuis RK and Van Dorp DA. The enzymic conversion of all-cis-8, 11, 14-eicosatrienoic acid into prostaglandin Er Rcc Trav Chim. Pays-Bas, 1966; 85–405–19.
   Google Scholar
• Palmer RJ, Stepney R, Higgs GA and Eakins KE. Chemokinetic activity of arachidonic acid lipoxygenase products on leukocytes from different species. Prostaglandins., 1980; 20; 411–8.
   Google Scholar
• Kuehl FA Jr and Egan RW. Prostaglandins, Arachidonic acid and inflammation. Science., 1980; 210; 978–84.
   Google Scholar
• Hamberg M, Hedqvist P and Radegran K. Identification of 15-hydroxy-5, 8, 11, 13-eicosatetraenoic acid (15-HETE) as a major metabolite of arachidonic acid in human lung. Acta Physiol Scand., 1980; 110; 219–21.
   Google Scholar
• Bryant RW and Bailey JM. In: Samuelsson B, Ramwell PW and Paoletti R, eds. Isolation of glucose sensitive platelet lipoxygenase products from arachidonic acid. Advances in Prostaglandins and Thromboxane Research. New York: Raven Press, 1980; 6: 95–9.
   Google Scholar
• Walker IC, Jones RL, Kerry PJ and Wilson NH. In: Samuelsson B, Ramwell PW and Paoletti R, eds. An epoxy-hydroxy product from arachidonate. Advances in Prostaglandin and Thromboxane Research. New York: Raven Press, 1980; 6; 107–9.
   Google Scholar
• Higgs GA, Eakins KE, Moncada S and Vane JR. In: Rainsford KD and Ford-Hutchinson AW, eds. Arachidonic acid metabolism in inflammation and the mode of action of antiinflammatory drugs. Agents and Actions (suppl. 6 Prostaglandins and fnflammation). Basel, Boston, Stuttgart: Birkhauser Verlag, 1979: 167–75.
   Google Scholar
• Samuelsson B and Hammarstrom S. Nomenclature for leukotrienes. Prostaglandins., 1980; 19: 645–8.
   Google Scholar
• Borgeat P and Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes: Formation of a novel dihydroxieicosatetraenoic acid. J Biol Chem., 1979; 254; 2643–6.
   Google Scholar
• Samuelsson B, Borgeat P, Hammarstrom S and Murphy RC. In: Samuelsson B, Ramwell PW and Paoletti R, eds. Leukotrienes; A new group of biologically active compounds. Advances in Prostaglandin and Thromboxane Research. New York: Raven Press, 1980; 6: 1–18.
   Google Scholar
• Radmark O, Malmsten C, Samuelsson B, Coto G, Marfat A and Corey EJ. Leukotriene A. Isolation from human polymorphonuclear leukocytes. J Biol Chem., 1980; 255: 11828–31.
   Google Scholar
• Feldberg W and Kellaway CH. Liberation of histamine and formation of lysolecithin-Iike substance by cobra venom. J Physiol Lond., 1938; 94: 187–226.
   Google Scholar
• Kellaway CH and Trethewie ER. The liberation of slow-reacting smooth-muscle stimulating substance in anaphylaxis. Quart J Exp Physiol, 1940; 30: 121–45.
   Google Scholar
• Stechschulte DJ. In: Weissmann G, ed. Slow reacting substances, mediators of inflammation. New York: Plenum Press, 1974: 181–97.
   Google Scholar
• Brocklehurst WE. In: Kallos P and Waksrnan BH, eds. Slow reacting substances and related compounds. Progress in Allergy. Basel: Karger, 6: 539–58.
   Google Scholar
• Anggard E, Bergvist U, Hogberg B, Johansson K, Tlion IL and Uvnas B. Biologically active principles occuring on histamine release from cat paw, guinea-pig lung and rat mast cells. Acta Physiol Scand, 1963; 59: 97–110.
   Google Scholar
• Lewis GP. Biochemistry, pathophysiology and pharmacology of slow reacting substances/leukotrienes. Agents and Actions, supplement devoted to the 3rd european workshop on inflammation. Paris: march 1981 in press.
   Google Scholar
• Green AF, Garland LG and Hodson HF. In: Vane IR and Ferreira SH, eds. Antagonists of histamine, 5-hydroxytryptamine and SRSA. Handbook of Experimental Pharmacology. Berlin, Heidelberg, New York: Springer Verlag, 1979; vol 50/2: 415–66.
   Google Scholar
• Walker JL. In Bergstrom S and Bernhard S, eds. The regulatory function of prostaglandins in the release of histamine and SRS-A from passively sensitized human lung tissue. Advances in Biosciences. Braunschweig: Pergamon Press, 1973; 9: 235–9.
   Google Scholar
• Engineer DM, Piper PJ and Sirois P. Interaction between the release of SRS-A and prostaglandins. Br J Pharmac, 1976; 57: 460P.
   Google Scholar
• Engineer DM, Niederhauser U, Piper PJ and Sirois P. Release of mediator of anaphylaxis: Inhibition of prostaglandin synthesis and the modification of release of slow-reacting substances of anaphylaxis ans histamine. Br J Pharmac., 1978; 62: 61–6.
   Google Scholar
• Smith AP. Effect of indomethacin in asthma: evidence against a role for prostaglandins in its pathogenesis. Br J Clin Pharmac., 1975; 2: 307–9.
   Google Scholar
• Jakschik BA, Falkenheim S and Parker CW. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc Nat Acad Sci. U.S.A., 1977; 74: 4577–81.
   Google Scholar
• Jakschik BA, Lee HL, Shuffer G and Parker CW. Arachidonic acid metabolism in rat basophilic leukemia (RBL-1) cells. Prostaglandins., 1978; 16: 733–48.
   Google Scholar
• Bach MK, Brashler JR and Gorman RR. On the structure of slow reacting substance of anaphylaxis: Evidence of biosynthesis from arachidonic acid. Prostaglandins., 1977; 14: 21–38.
   Google Scholar
• Sirois P, Moore EG and Orange RP. Further evidence on the structure of slow reacting substance of anaphylaxis (SRS-A). Agents and Actions., 1979; 9: 337–43.
   Google Scholar
• Orange RP and Chang PL. The effect of thiols on immunologic zelease of slow reacting substance of anaphylaxis.1 Human Lung. J Immunol., 1975; 115: 1072–7.
   Google Scholar
• Sirois P. Engineer DM, Piper PJ and Moore EG. Comparison between rat, mouse, guineapig and human slow reacting substance of anaphylaxis (SRS-A). Experientia., 1979; 35: 361–2.
   Google Scholar
• Morris HR, Taylor GW, Piper PJ, Sirois P and Tippins JR. Slow reacting substance of anaphylaxis: purification and characterization. FEBS letters., 1978; 87: 203–6.
   Google Scholar
• Murphy RC, Hammarstrom S and Samuelsson B. Leukotriene in, a slow reacting substance (SRS) from mouse mastocytoma cells. Proc Nat Acad Sci. USA, 1979; 76: 4275–9.
   Google Scholar
• Hammarstrom S, Murphy RC, Samuelsson B, Clark DA, Mioskowski C and Corey EJ.Structure of leukotriene C. Identification of the amino-acids part. Biochem Biophys Res Commun., 1979; 91: 1266–72.
   Google Scholar
• Corey EJ, Arai Y and Mioskowski C. Total synthesis of (±)-5, 6-oxido-7, 9-trans-ll, 14-cis-eicosatetraenoic acid, a possible precursor of SRS-A. J Am Chem Soc., 1979; 101: 6748–9.
   Google Scholar
• Radmark O, Malmsten C, Samuelsson B, Clark DA, Coto G, Marfat A and Corey EJ. Leukotriene A. Stereochemistry and enzymatic conversion to leukotriene B. Biochem Biophys Res Commun., 1980; 92: 954–61.
   Google Scholar
• Morris HR, Taylor GW, Piper PJ, Samhoun MN and Tippins JR. Slow reacting substances (SRSs): The structure identification of SRSs from rat basophilic leukemia (RBL-1) cells. Prostaglandins., 1980; 19; 185–201.
   Google Scholar
• Orning L, Hammarstrdm S and Samuelsson B. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. I’roc Natl Acad Sci. VSA, 1980; 77: 2014–7.
   Google Scholar
• Samuelsson B. The leukotrienes: a new group of biologically active compounds including SRS-A. TIPS., 1980; 1: 227–30.
   Google Scholar
• Parker CW, Koch DA, Huber MM and Falkenheim SF. Arylsulfatase inactivation ot slow reacting substance. Evidence for proteolysis as a major mechanism when ordinary commercial preparations of the enzyme are used. Prostaglandins., 1980; 20: 887–908.
   Google Scholar
• Ohnishi H, Kosuzume H, Kitamura Y Yamaguchi K. Nobuhara M and Susuk. i. Structure of slow reacting substance of anaphylaxis (SRS-A). Prostaglandins., 1980, 20: 655–66.
   Google Scholar
• Ford-Hutchinson AW, Bray MA, Cunningham FM, Davidson EM and Smith MJH. Isomers of leukotriene 13, possess different biological potencies. Prostaglandins., 1981; 21: .
   Google Scholar
• Smith MJH and Ford-Hutchinson AW. Leukotriene B: a potential mediator of inflammation. J. Pharm Pharmac., 1980; 32: m/-o.
   Google Scholar
• Klickstein LB, Shapleigh C and Goetzl EJ. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue inrheumatoid arthritis and spondylarthritis. J. Clin. Inves., 1980; 66: 1166–70.
   Google Scholar
• Welton AF, Crowley HJ, Miller DA and Yaremko B. Biological activities of a chemically synthesized form of leukotriene E(. Prostaglandins., 1981; 21: 287–96.
   Google Scholar
• Roberts LJ II, Sweetman BJ, Lewis RA, Austen KF and Oates JA. Increased production of prostaglandins D, in patients with systemic mastocytosis. N Engl J Med., 1980; 303: 1400–4.
   Google Scholar
• Benveniste J. Platelet-activating factor (PAFacether): present status. Agents and Actions, supplement devoted to the 3rd european workshop of inflammation, Paris, march 1981, in press.
   Google Scholar
• Garland LG, Green AF and Hodson HF. In: Vane JR and Ferreira SH, eds. Inhibitors of the release of anaphylactic mediators. Handbook of Experimental Pathology. Berlin, Heidelberg, New York: Springer Verlag, 1979; 50/2: 467–530.
   Google Scholar
• Walker JR and Dawson W. Inhibition of rabbit polymorphonuclear lipoxygenase activity by benoxaprofen. J Pharm Pharmacol., 1979; 31: 779–81.
   Google Scholar
• Higgs GA and Flower RJ. In: Piper PJ, ed. Antiinflammatory drugs and inhibition of arachidonate lipoxygenase. SRS-A and leukotrienes. Chichester, New York, Brisbane, Toronto: John Wiley and Sons Ltd, 1981: 197–207.
   Google Scholar
• Walker JL. In: Samuelsson B, Ramwell PW and Paoletti R, eds. Interrelationship of SRSA production and arachidonic acid metabolism in human lung tissue. Advances in prostaglandin and thromboxane research. New York: Raven Press, 1980; 6: 115–9.
   Google Scholar
• Flower RJ and Blackwell. Antiinflammatory steroids induce biosynthesis of a phospholipase A. inhibitor which prevents prostaglandin generation. Nature Lond., 1979; 278: 456–9.
   Google Scholar
• Palmer MR, Mathews R, Murphy RC and Hoffer BJ. Leukotriene C elicits a prolonged excitation of cerebellar Purkinje neurons. Neuroscience letters., 1980; 18: 173–80.
   Google Scholar